These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

50 related items for PubMed ID: 15625339

  • 1. A new treatment for ocular neovascularization.
    Ferris FL.
    N Engl J Med; 2004 Dec 30; 351(27):2863-5. PubMed ID: 15625339
    [No Abstract] [Full Text] [Related]

  • 2. Photodynamic therapy in the anti-VEGF era.
    Fine HF.
    Br J Ophthalmol; 2007 Jun 30; 91(6):707-8. PubMed ID: 17510474
    [Abstract] [Full Text] [Related]

  • 3. Anti-Vascular Endothelial Growth Factor Injection for Exudative Age-related Macular Degeneration in Patients with Vitreo-Macular Traction.
    Querques G.
    Am J Ophthalmol; 2009 Feb 30; 147(2):375-6; author reply 376-7. PubMed ID: 19166716
    [No Abstract] [Full Text] [Related]

  • 4. Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment.
    Busch T.
    Retina; 2009 Jun 30; 29(6 Suppl):S36-8. PubMed ID: 19553798
    [Abstract] [Full Text] [Related]

  • 5. Towards a rational approach to combination therapy for neovascular age-related macular degeneration.
    Arroyo JG.
    Br J Ophthalmol; 2007 Feb 30; 91(2):130-1. PubMed ID: 17244655
    [Abstract] [Full Text] [Related]

  • 6. Ranibizumab and stroke.
    Ueta T, Yanagi Y, Tamaki Y, Yamaguchi T.
    Ophthalmology; 2010 Sep 30; 117(9):1860; author reply 1860-1. PubMed ID: 20816253
    [No Abstract] [Full Text] [Related]

  • 7. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
    Kaiser PK, Blodi BA, Shapiro H, Acharya NR, MARINA Study Group.
    Ophthalmology; 2007 Oct 30; 114(10):1868-75. PubMed ID: 17628683
    [Abstract] [Full Text] [Related]

  • 8. Strategies for inhibiting vascular endothelial growth factor.
    Kaiser PK.
    Retina; 2009 Jun 30; 29(6 Suppl):S15-7. PubMed ID: 19553789
    [Abstract] [Full Text] [Related]

  • 9. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Arias L, Ruiz-Moreno JM, Gómez-Ulla F, Fernández M, Montero J.
    Retina; 2009 Jun 30; 29(10):1444-9. PubMed ID: 19730163
    [Abstract] [Full Text] [Related]

  • 10. Value-based medicine.
    Kymes SM, Vollman D, Frick KD.
    Ophthalmology; 2008 Nov 30; 115(11):2099; author reply 2100. PubMed ID: 19068385
    [No Abstract] [Full Text] [Related]

  • 11. Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with vitelliform macular dystrophy.
    Querques G, Bocco MC, Soubrane G, Souied EH.
    Acta Ophthalmol; 2008 Sep 30; 86(6):694-5. PubMed ID: 18752521
    [No Abstract] [Full Text] [Related]

  • 12. Pathology beyond neovascularization: new targets in age-related macular degeneration.
    Heier JS.
    Retina; 2009 Jun 30; 29(6 Suppl):S39-41. PubMed ID: 19553799
    [Abstract] [Full Text] [Related]

  • 13. Age-related macular degeneration.
    Brucker AJ.
    Retina; 2009 Jun 30; 29(6 Suppl):S2-4. PubMed ID: 19553791
    [Abstract] [Full Text] [Related]

  • 14. Combination angiostatic therapies: current status.
    Peyman GA, Fiscella R, Conway M.
    Retina; 2009 Jun 30; 29(6 Suppl):S18-20. PubMed ID: 19553790
    [Abstract] [Full Text] [Related]

  • 15. Inhibiting angiogenesis in retinoblastoma.
    Apte RS, Harbour JW.
    Ophthalmic Res; 2007 Jun 30; 39(4):188-90. PubMed ID: 17556838
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Re: development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ziemssen F, Heiduschka P, Schraermeyer U, Tübingen Bevacizumab Study Group.
    Retina; 2007 Oct 30; 27(8):1154-6; author reply 1156-8. PubMed ID: 18040264
    [No Abstract] [Full Text] [Related]

  • 18. Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration.
    Barouch FC, Miller JW.
    Int Ophthalmol Clin; 2004 Oct 30; 44(3):23-32. PubMed ID: 15211174
    [No Abstract] [Full Text] [Related]

  • 19. [Intravitreal dexamethasone as an enhancer for the anti-VEGF treatment in neovascular ARMD: recovering an old ally].
    Gallego-Pinazo R, Marín-Lambíes C, Marín-Olmos F, Martínez R, Fons R, Díaz-Llopis ML, Díaz-Llopis ML, Díaz-Llopis ML.
    Arch Soc Esp Oftalmol; 2010 Feb 30; 85(2):79-80. PubMed ID: 20566180
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.